About Index Trending news
Lists
Pricing
Immunovaccine Inc.

Immunovaccine Inc.

Immunovaccine Inc.

Immunovaccine Inc. (TSX-V: IMV) develops vaccines, using its patented delivery platform – DepoVax™ – for therapeutic cancer and infectious diseases.
Founded
2000
Raised
$17M
Follow us
Contributors
Alexa global traffic share